Volume 16, Number 12—December 2010
Imported Leishmaniasis in Dogs, US Military Bases, Japan
Highlight and copy the desired format.
|EID||Kawamura Y, Yoshikawa I, Katakura K. Imported Leishmaniasis in Dogs, US Military Bases, Japan. Emerg Infect Dis. 2010;16(12):2017-2019. https://dx.doi.org/10.3201/eid1612.100389|
|AMA||Kawamura Y, Yoshikawa I, Katakura K. Imported Leishmaniasis in Dogs, US Military Bases, Japan. Emerging Infectious Diseases. 2010;16(12):2017-2019. doi:10.3201/eid1612.100389.|
|APA||Kawamura, Y., Yoshikawa, I., & Katakura, K. (2010). Imported Leishmaniasis in Dogs, US Military Bases, Japan. Emerging Infectious Diseases, 16(12), 2017-2019. https://dx.doi.org/10.3201/eid1612.100389.|
To the Editor: Leishmaniasis is found in canids in ≈50 of the 88 countries where leishmaniases are found in humans (1). In Japan, 2 cases of imported canine leishmaniasis have been documented in dogs from Spain (2,3). We report 2 cases of leishmaniasis in dogs in which dermatitis developed mainly on the face. Leishmaniasis was diagnosed from results of a serologic rk39 test, followed by PCR of skin lesion specimens for the Leishmania spp.–specific small subunit (SSU) rRNA gene. Because the dogs had lived on a US military base in Sicily, Italy, for 3 years before their owners were transfered to Japan, the animals were likely infected with L. infantum in Italy.
Animal 1 was a 6-year-old female dog that had lived in Sicily for 3 years, since 2003, and had been brought to Japan in September 2006. While she lived in Italy, she had exhibited alopecic, pruritic, and crusty skin lesions, mainly around the face and on the forearms and hind legs.
In November 2006, the dog was brought to the US Army Veterinary Command’s Zama Veterinary Treatment Facility with dermatitis (Figure A1, panel A) and additional signs of kidney failure. A serum specimen was positive by the rk39 dipstick test for diagnosis of visceral leishmaniasis (Kalazar Detect; InBios, Seattle, WA, USA). A skin punch biopsy specimen was obtained for cultures and PCR for the parasites in December 2006. Cultures of 4 skin specimens were all negative, probably because of cool transportation of the samples for 1.5 days before the cultures were started. The dog’s condition was treated with ketoconazole and then allopurinol. The skin conditions initially improved, but the lesions did not completely resolve (Figure A1, panels B–D). In May 2008, the dog was humanely killed because of central vestibular disease with unknown cause. A necropsy was not performed.
Animal 2 was a 12-year-old male dog that had also lived in Sicily for 3 years since 2000, and was brought to Yokosuka Base in Japan in 2003. In January 2004, the dog was positive for visceral leishmaniasis by the rk39 test; no particular clinical signs were observed.
In March 2007, the dog was referred to Zama Veterinary Treatment Facility with pruritic alopecia on the dorsum and head, and a skin punch biopsy specimen was obtained for histopathologic evaluation. The presence of amastigotes of Leishmania species within areas of dermal inflammation was confirmed at the Armed Forces Institute of Pathology (Washington, DC, USA). In April 2007, a second skin punch biopsy specimen was obtained for PCR.
PCR was performed for the Leishmania-specific SSU rRNA gene (4). For primary PCR, primers R221 (5′-GGTTCCTTTCCTGATTTACG-3′) and R332 (5′-GGCCGGTAAAGGCCGAATAG-3′) were used. For nested PCR, primers R223 (5′-TCCCATCGCAACCTCGGTT-3′) and R333 (5′-AAAGCGGGCGCGGTGCTG-3′) were used. In the primary reaction, the expected PCR products of ≈603 bp were detected in 2 of 4 skin DNA specimens from patient 1 and 1 of 5 skin DNA specimens from patient 2 (Figure, panel A, lanes 2, 3, 9). In the nested reaction, the expected PCR products of ≈359 bp were seen in all 4 specimens from patient 1 and in 4 of 5 specimens from patient 2 (Figure, panel B, lanes 1–4, and 5, 6, 8, 9); some bands were faint. The nucleotide sequences (288 bp) of the nested PCR product of patient 1 were 100% identical to those of patient 2 and sequences of the SSU rRNA gene of L. infantum (IPT1 strain, used as a positive control), L. infantum (M81429), L. donovani (M80295), and L. chagasi (M81430).
Global warming, which causes changes in the distribution of the sand fly vectors, and human-produced risk factors, such as travel, migration, and urbanization, may increase the incidence of leishmaniasis (5). Military mobility and operations are also a major risk factor for leishmaniasis in humans and canids (6). In Japan, of >300 kala-azar (visceral leishmaniasis) patients reported, 218 were soldiers who returned from the People’s Republic of China before and after World War II (7). In the present study, 2 dogs infected with L. infantum had been brought to Japan from Italy by US military families.
Dog-to-dog transmission by direct contact with contaminated blood through biting may explain the recent outbreaks of leishmaniasis in foxhounds in North America (8). In Japan, although no sandfly species that could transmit leishmania have been reported (7), direct dog-to-dog transmission of leishmaniasis can occur. Babesia gibsoni infection is prevalent among fighting dogs in Japan, likely because of the transmission of infected erythrocytes through biting (9). Greater sharing of information and of diagnostic procedures is required in Japan because few medical and veterinary practitioners have experience with leishmaniasis patients.
This study was supported in part by grants from the Global Center of Excellence program for International Collaboration Centers for Zoonosis Control and grant no. 183801780 from the Ministry of Education, Culture, Sport, Science and Technology of Japan.
- Alvar J, Cañavate C, Molina R, Moreno J, Nieto J. Canine leishmaniasis. Adv Parasitol. 2004;57:1–88.
- Namikawa K, Watanabe M, Lynch J, Sugaki Y, Kitai T, Sunaga F, A canine case of Leishmania infantum infection in Japan. Jpn J Vet Dermatol. 2006;12:11–5.
- Takahashi N, Naya T, Watari T, Matsumoto Y, Matsumoto Y, Tsujimoto H, An imported case of canine cutaneous leishmaniasis in Japan. Jpn J Vet Dermatol. 1997;3:25–7.
- Van Eys GJ, Schoone GJ, Kroon NC, Ebeling SB. Sequence analysis of small subunit ribosomal RNA genes and its use for detection and identification of Leishmania parasites. Mol Biochem Parasitol. 1992;51:133–42.
- Desjeux P. The increase in risk factors for leishmaniasis worldwide. Trans R Soc Trop Med Hyg. 2001;95:239–43.
- Coleman RE, Bukert DA, Putma JL, Sherwood V, Caci JB, Jennings BT, Impact of Phlebotomine sand flies on U.S. military operations at Talli air base, Iraq: 1. background, military situation, and development of a “leishmaniasis control program.”. J Med Entomol. 2006;43:647–62.
- Katakura K. Molecular epidemiology of leishmaniasis in Asia (focus on cutaneous infections). Curr Opin Infect Dis. 2009;22:126–30.
- Duprey ZH, Steurer FJ, Rooney JA, Kirchhoff LV, Jackson JE, Rowton ED, Canine visceral leishmaniasis, United States and Canada, 2000–2003. Emerg Infect Dis. 2006;12:440–6.
- Miyama T, Sakata Y, Shimada Y, Ogino S, Watanabe M, Itamoto K, Epidemiological survey of Babesia gibsoni infection in dogs in eastern Japan. J Vet Med Sci. 2003;67:467–71.
- Figure. PCR amplification of the Leishmania spp.–specific small subunit rRNA gene from skin biopsy specimens from infected dogs, Japan. DNA samples (100–200 ng) were subjected to primary PCR (A), followed by...
- Figure A1. Animal 1 with alopecic, pruritic, and crusty skin lesions mainly around the face, head, margins of ear pinnae, cranial aspect of the elbows and forearms, and caudal aspect of...
Please use the form below to submit correspondence to the authors or contact them at the following address:
Ken Katakura, Laboratory of Parasitology, Department of Disease Control, Graduate School of Veterinary Medicine, Hokkaido University, Kita 18 Nishi 9, Kita-ku Sapporo 060-0818, Hokkaido, Japan
Comment submitted successfully, thank you for your feedback.
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
- Page created: August 28, 2011
- Page last updated: August 28, 2011
- Page last reviewed: August 28, 2011
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)